|
|
Volumn 25, Issue 3, 2015, Pages 183-184
|
|
Focal therapy of prostate cancer: Making steady progress toward a first-line image-guided treatment modality
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MOLECULAR MARKER;
PROSTATE SPECIFIC ANTIGEN;
ABLATION THERAPY;
COST;
ECHOGRAPHY;
EDITORIAL;
FOCAL THERAPY;
HISTOPATHOLOGY;
HUMAN;
MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OUTPATIENT;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROSTATE CANCER;
TRANSRECTAL ULTRASONOGRAPHY;
TREATMENT PLANNING;
TUMOR VOLUME;
ULTRASOUND;
COMPUTER ASSISTED SURGERY;
INTERVENTIONAL MAGNETIC RESONANCE IMAGING;
MALE;
PATHOLOGY;
PROSTATE;
PROSTATIC NEOPLASMS;
REPRODUCIBILITY;
SENSITIVITY AND SPECIFICITY;
TRANSRECTAL HIGH INTENSITY FOCUSED ULTRASOUND;
HUMANS;
MAGNETIC RESONANCE IMAGING, INTERVENTIONAL;
MALE;
PATIENT SELECTION;
PROSTATE;
PROSTATIC NEOPLASMS;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SURGERY, COMPUTER-ASSISTED;
ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;
|
|
EID: 84928537212
PISSN: 09630643
EISSN: 14736586
Source Type: Journal
DOI: 10.1097/MOU.0000000000000171 Document Type: Editorial |
|
Times cited : (4)
|
|
References (0)
|
